Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Clinical trial condition

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Explore clinical trials studying Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma trial results

Active, not recruiting

Phase I Clinical Study of JS203 in Patients With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

NCT05618327

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Completed

Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma

NCT05322330

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details